Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DHR39I
|
|||
| Drug Name |
AZD3427
|
|||
| Indication | Heart failure [ICD-11: BD10-BD13] | Phase 2 | [1] | |
| Pulmonary hypertension [ICD-11: BB01; ICD-10: I27, I27.0; ICD-9: 416] | Phase 2 | [1] | ||
| Company |
AstraZeneca
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05737940) A Phase IIb Randomised, Double-blind, Placebo-controlled, Multi-centre, Dose-ranging Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Due to Left Heart Disease (WHO Group 2). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.